A carregar...
Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation
BRAF mutation is one of the important driver oncogene in non‐small‐cell lung cancer (NSCLC). Data on Chinese patients with BRAF‐mutant NSCLC are inadequate. Hence, we conducted this study to investigate the clinicopathologic features and outcomes of Chinese patients with NSCLC and BRAF mutations. We...
Na minha lista:
Publicado no: | Cancer Med |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5345676/ https://ncbi.nlm.nih.gov/pubmed/28135039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1014 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|